Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Taking the family-owned CDMO global

Taking the family-owned CDMO global

FromMolecule to Market: Inside the outsourcing space


Taking the family-owned CDMO global

FromMolecule to Market: Inside the outsourcing space

ratings:
Length:
34 minutes
Released:
Jul 13, 2020
Format:
Podcast episode

Description

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Bobby Sheng, CEO and Chairman of Bora Pharmaceuticals.  A California native and an experienced leader in the pharmaceutical industry, Bobby is skilled in international business, management, mergers & acquisitions, finance, and marketing. He graduated from University of California, Berkeley and now resides in Taiwan.  
Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with guest Bobby Sheng, speaking on Bobby’s time as a producer in the film industry and the lessons he gained from producing nine films. Bobby explains his key focus areas as a leader and how he tries to keep them top of mind as he progresses through his career. He also explains the importance of having the right people on your team and describes them as the best and strongest asset an organization can have. Lastly, Bobby speaks on the pharma production industry. He believes there is room to adopt efficiencies and technologies in order to move away from the archaic batch production system.  
Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also love a positive rating! Molecule to Market is sponsored and funded by ramarketing. An international content, design and digital agency that helps companies get noticed, raise profile and generate leads in life sciences.
Released:
Jul 13, 2020
Format:
Podcast episode

Titles in the series (100)

Molecule to Market takes you inside the contract outsourcing space with industry insights and thoughts direct from the brains of the people that make the headlines. Talking everything from pharmaceutical contract research, development and manufacturing to clinical trial packaging, logistics and technology – Molecule to Market is a vital shot of infotainment for anyone who wants in on outsourcing.